Skip to search.
 FTSE 100 Up 0.62%
Streaming
Ticker Tape: On

Biogen Idec Inc. (BIIB)

-NasdaqGS
290.54 Down 0.94(0.32%) 17 Apr 21:00
|After Hours: : 289.99 Down 0.55 (0.19%) 18 Apr 00:58
Add to Portfolio
Prev Close:291.48
Open:291.00
Bid:287.30 x 100
Ask:298.00 x 100
1y Target Est:345.24
Beta:1.34
Next Earnings Date:23-Apr-14BIIB Earnings announcement
Day's Range:289.76 - 296.00
52wk Range:194.66 - 358.89
Volume:1,283,744
Avg Vol (3m):1,788,190
Market Cap:68.68b
P/E (ttm):37.20
EPS (ttm):7.81
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 0.32%68.68b
PFEUp 0.53%193.08b

Key Statistics

Forward P/E (1 yr):20.63
P/S (ttm):9.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :11.32
Quarterly EPS Est (Mar-14) :2.56
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback